TNFSF11 and myeloid sarcoma: In this study, we observed significant differences in the serum concentration of RANKL and the ratio of RANKL/OPG during AI therapy between cases and controls, suggesting that AI-related MS-AEs are associated with the RANKL/RANK/OPG bone remodeling pathway.